however, their experience with injuries and illnesses due to acute whole-body (or large partial body) exposures may be lacking. Further, these specialists may not recognize atypical presentations of acute radiation syndrome (ARS) in these patients. Cases of local or partial body exposure are more common and yet are still rare. 2 Currently, few physicians would be able to recognize the IR symptom complex and be aware of the initial treatments.
The aim of this article is to help increase physician knowledge and recognition of ARS by reviewing the basics of the pathophysiologic process, clinical signs and symptoms, laboratory findings, dose estimation, and treatment planning of ARS.
Pathophysiologic Process of ARS
Ionizing radiation damages the molecules that make up the cells of the various tissues of the body. The effects on cells and cellular structures occur in several ways. The energy released from an ionization can break atomic bonds directly or indirectly. Indirect ionization results from the hydrolysis of water, which releases highly reactive free radicals that cause breakage of the bonds and other damage. 3 The major target in cells is DNA. The damage may be a single-stranded DNA break or a double-stranded DNA break, with the latter being more difficult to repair and often resulting in chromosomal aberrations and mutations. 3 Double-stranded DNA breaks often lead to cellular death. Ionizing radiation may also alter the cell cycle by arresting it, delaying it, or delaying replication with the aberrant chromosomal material. The cell often detects these anomalies and then commits cellular suicide by apoptosis. Cellular death by apoptosis is not accompanied by an inflammatory process, whereas mitotic death and necrosis are associated with an inflammatory response.
All of these processes may occur with IR exposure, resulting in a hyperinflammatory and a hypercytokinemic-like syndrome. Systemic inflammatory response syndrome and multiorgan dysfunction often result in multiorgan failure in all organ-irradiated systems and death. [4] [5] [6] [7] A continuum of changes occur so that there is ongoing damage to all of the affected organ systems simultaneously. 8 The ARS subsyndromes-hematopoietic, gastrointestinal (GI), neurovascular, and cutaneous subsyndromes-represent the "classic" presentation of damage to the given organ system and at the doses where changes are typically seen. This article focuses on the former 3 subsyndromes. Figure 2 ).
Hematopoietic Subsyndrome
The classic presentation of hematopoietic ARS is seen at doses greater than 1 Gy and manifest earlier and 
Symptoms of ARS
One of the earliest effects of IR exposure to the whole body or to a large portion of the whole body is a prodromal period of nonspecific signs and symptoms such as nausea, emesis, fatigue, fever, and anorexia. As in the example from Goiânia, Brazil, patients may be unaware of their exposure to radioactive materials. Thus, physicians need to maintain a high index of suspicion when seeing multiple patients with similar patterns of these symptoms. The prodrome may be followed by a latent phase in which patients have a decrease or absence of symptoms. In the manifest illness phase of ARS, the signs and symptoms of damage to a particular cell type or organ will fully exhibit the disease. The severity of the prodrome period is proportional to the dose received and, therefore, the degree of illness manifestation.
The persistence of emesis and diarrhea along with fever are poor prognosticators. The presence of emesis may be used as an initial indicator of dose (Table 1) , although it is more accurate when used with other parameters. Acute radiation syndrome presents as a complex of its aforementioned subsyndromes. Although hematopoietic, GI, neurovascular, and cutaneous ARS are recognized as the traditional subsyndromes of ARS, an ongoing spectrum of damage occurs in all affected organ systems; there is no isolated damage to one system without some effect on another. 9 The classic presentations of the subsyndromes, however, appear at certain dose thresholds ( Table 2) . Injury to the skin may be as deadly or more so than the other subsyndromes.
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Several entities have assigned grading systems to the subsyndromes to assist in the triage and treatment of these patients.
8,9
The median lethal dose that can be expected to result brile neutropenic patients. 13 Consultation with an infectious disease specialist should always be considered. 
GI Subsyndrome
The classic presentation of GI ARS is seen at doses greater than 5 to 6 Gy. The initial nausea and emesis of the prodrome are believed by some authorities to be caused centrally. Factors other than cellular radiosensitivity that may determine the effects of ionizing radiation. Delayed effects of acute radiation exposure that are still considered to be deterministic include late organ effects, such as vascular changes, fibrosis, atrophy, thyroid dysfunction, cataracts, and infertility. The probability of a cancer forming is based on chance and is therefore a stochastic effect. For stochastic effects, as the radiation dose increases, the probability of a cancer developing increases, but the cancer itself does not become "worse."
Radiation Factors

Biodosimetric and Multiparameter Dose Estimation
As soon as possible after a radiologic incident, it is important to involve a health or medical physicist familiar with performing incident recreations, which can estimate the radiation dose sustained and thereby guide patient treatment.
An early study by the National Aeronautics and
Space Administration performed at Oak Ridge Associated Universities evaluated the radiation dose dependence of the prodromal symptoms of anorexia, nausea, and vomiting. 16 From this work, the effective doses needed to produce a 50% incidence of symptoms were found to be 1.08 Gy for anorexia, 1.58 Gy for nausea, Neurovascular changes are believed by some to begin early and at low doses. 5 The classic picture of neurovascular ARS is seen with doses higher than 10 Gy. 15 The timing and severity are dose dependent. The WHO Consultancy lists strong evidence-based recommendations for supportive care, including 5HT3 antagonist, man- nausea is not considered. [19] [20] [21] [22] In addition to time to emesis (a clinical biodosimetric parameter) and lymphocyte depletion kinetics (a laboratory biodosimetric parameter), 22, 23 other laboratory parameters can be effective determinants. Serum amylase will be notably elevated if the head and neck area is involved in the irradiated field 24 or there is severe abdomdose. In addition, a quantitative method to calculate available time to emesis has been published, 17 and analysis of the sensitivity and specificity of the time to emesis as a sole parameter has also been reported. 18 This method is a useful tool, especially in an environment where other methods of testing are not available.
When evaluating patients suspected of sustaining a high radiation dose, serial CBC counts with WBC differentials are needed to evaluate the dose-dependent lymphocyte depletion seen at doses greater than 1 Gy.
In the early phase of hematopoietic ARS, neutrophils (N) usually increase, owing to a systemic stress response and resultant demargination from blood vessels, and lymphocytes (L) decrease. The ratio between numbers of N and numbers of L is pertinent for biodosimetric purposes. For initial triage of a patient suspected of having a clinically high radiation dose, the quantity R=N/L± is determined, where N is the ANC, L is the ALC, and R is calculated as promising technique being developed is the γ-H2AX assay, which looks for phosphorylated histone particles released from double-stranded DNA breaks. 7, 30 There is consensus that a multiparameter approach is the most beneficial in assessing dose.
Case Conclusion
Over the next few weeks, more than 112,000 people in It is worth noting that a patient may be exposed to a radiation source but not be contaminated. This means that the patient received a dose but does not have radioactive materials on or in his or her body. Also, a patient who is contaminated with radioactive materials either on or in his or her body can receive a dose from this con- Although there is not a consensus, some laboratory investigators have suggested that serial serum citrulline levels be drawn initially after a radiation exposure incident and then weekly thereafter. Elevations of serum citrulline levels as a measure of enteric biomass have been conducted in humans undergoing radiation therapy, and the molecule has been measured in casualties of radiation incidents. As the GI mucosa sloughs, enteric biomass and serum citrulline level decrease.
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The criterion standard for biodosimetry is the cytogenetic dicentric assay. 22, 28 This technique looks for radiation-induced chromosomal aberrations, called dicentrics.
These dicentrics-1 cell that has a chromosome without a centromere and 1 cell that has 2 centromeres-result from the misrepair that occurs during the cell cycle. One limitation of this test is that it relies on using lymphocytes; with doses greater than 5 Gy, there will not be Severe, 4-6 Gy (400-600 rad) Very Severe, 6-8 Gy (600-800 rad) Lethal, >8 Gy (>800 rad) Hematopathology and infectious disease consultation is needed in most cases.
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